We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-2 of 2

Failure-to-warn claims against generic drug makers preempted
  • Shook Hardy & Bacon LLP
  • USA
  • June 24 2011

Yesterday, the U.S. Supreme Court shut the door on failure-to-warn claims filed against generic drug manufacturers